Ipsen at a glance

Ipsen is a global biopharmaceutical group dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. We also have a well-established and successful Consumer Healthcare business. We are committed to discovering new solutions for targeting debilitating diseases and improving the quality of life for patients.

€ 1.909 billion

Sales

> 5,400

Employees worldwide

8

R&D centers

History

Since it was founded in 1929, by Henri Beaufour, Ipsen has developed, and made available to patients, a number of products in Oncology, Neuroscience, Rare Diseases and Consumer Healthcare. Global footprint, acquisitions, partnerships, scientific collaborations and innovations: learn about the development of our group over the years.

Leadership

Discover all the information relating to the leadership teams of the Ipsen Group: presentation of the executive management and composition of the Board Committees.

Strategy

Our strategy is to build a global biopharma company focused on innovation and specialty care which delivers differentiated therapeutics to meet unmet patient needs. Our biotech mindset – combined with the scale and advantages of a global biopharmaceutical company – has already established us as a development and commercial powerhouse in our core focused areas, with a proven ability to bring new, life changing therapies to market.

Locations

The Ipsen Group’s medicines are used in over 115 countries across the globe. Our extensive and diversified geographic footprint allows us to meet the needs of patients at our commercial operations sites, industrial sites and R&D centers: Discover our Group’s locations on the interactive map.